gfdfh
@hca
According to PRNewswire, Anixa Biosciences, Inc. (NASDAQ: ANIX), a US listed company, announced that its board of directors has approved the purchase of Bitcoin as a treasury reserve asset, aimed at diversifying the company's assets and enabling Anixa to benefit from the potential long-term value of digital assets. It is reported that Anixa is a clinical stage biotechnology company specializing in cancer treatment and prevention. @gyozilla
0 reply
0 recast
0 reaction